Hannah Alison L.

CIK 0001645600

Chief Medical OfficerDirector

Filings

Latest May 19, 2026

Issuers covered

Showing

12 of 12

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Hannah Alison L.. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Hannah Alison L. has filed

Ticker	Issuer	Filings	Last filed
NEO	Neogenomics Inc	6	Jun 3, 2025
RIGL	Rigel Pharmaceuticals Inc	5	May 19, 2026
CTMX	Cytomx Therapeutics, Inc.	1	Feb 4, 2022

12 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 19, 2026	RIGLRigel Pharmaceuticals Inc	AGrant	5,750	$0.00	$0
Jun 3, 2025	NEONeogenomics Inc	AGrant	12,254	$0.00	$0
Jun 3, 2025	NEONeogenomics IncA	MExercise	12,254	$0.00	$0
May 28, 2025	RIGLRigel Pharmaceuticals Inc	AGrant	2,500	$0.00	$0
Aug 13, 2024	NEONeogenomics Inc	MExercise	11,336	$0.00	$0
Jun 4, 2024	NEONeogenomics Inc	Holdings only	-	-	-
May 29, 2024	RIGLRigel Pharmaceuticals Inc	AGrant	25,000	$0.00	$0
Aug 14, 2023	NEONeogenomics Inc	Holdings only	-	-	-
Jul 12, 2023	RIGLRigel Pharmaceuticals Inc	AGrant	25,000	$0.00	$0
Jun 14, 2022	NEONeogenomics Inc	AGrant	15,556	$0.00	$0
May 23, 2022	RIGLRigel Pharmaceuticals Inc	AGrant	25,000	$0.00	$0
Feb 4, 2022	CTMXCytomx Therapeutics, Inc.	AGrant	22,500	$0.00	$0

Showing 1-12 of 12

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.